• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Special Transfusion Situations

Gunshot Wounds Cause Significant Mortality, Blood Utilization, and Health Care Costs in the U.S.

Half of the world’s civilian firearms are owned by individuals in the United States.  The U.S. also leads all high-income…

July 6, 2021

Reducing Red Cell Use for Patients with Sickle Cell Disease during a Pandemic

Since March 2020, the COVID-19 pandemic has strained blood inventories, so researchers at one Philadelphia hospital implemented new measures to…

June 30, 2021

Population-Based Study in India Helps Refine Hemoglobin Thresholds for Anemia in Children

Since hemoglobin thresholds for anemia are currently based on data collected over 50 years ago in Caucasian adults, the WHO…

June 2, 2021

High Titer Convalescent Plasma Does Not Improve Survival of Hospitalized Patients with COVID-19

With few treatment options, more than 500,000 patients with COVID-19 were transfused with convalescent plasma in the United States.  Observational…

May 26, 2021

Tranexamic Acid To Reduce Blood Loss after Cesarean Delivery

Tranexamic acid is a common antifibrinolytic drug used to prevent blood loss during surgeries and treat heavy menstrual cycles.  Several…

May 5, 2021

SARS-CoV-2 Preferentially Binds Blood Group A Expressed on Epithelial Cells

Genome-wide studies and other observational studies have found an association between ABO(H) blood group and the likelihood of SARS-CoV-2 infection. …

March 24, 2021

Early Convalescent Plasma Therapy Helps Prevent Severe COVID-19

COVID-19 convalescent plasma administered late in the course of disease has not shown clear benefits, but some studies suggest that…

January 12, 2021

Serological Screening of Blood Donations Suggests SARS-CoV-2 May Have Been Introduced in the US before January 2020

The first case of SARS-Cov-2 in the United States was reported on January 19, 2020 in Washington State, but phylogenic…

December 22, 2020

CRISPR-Cas9 Gene Editing and Lentiviral Gene Therapy Hold Promise to Treat Transfusion Dependent β-Globin Hemoglobinopathies

Both transfusion-dependent β-thalassemia (TDT) and sickle cell disease (SCD) are common monogenetic diseases caused by mutations in the gene encoding…

December 15, 2020

FDA Issues Emergency Use Authorization for SARS-CoV-2 Monoclonal Antibody Therapy

Approximately 10% of COVID-19 cases lead to severe respiratory distress and hospitalization.  In an effort to develop specific therapeutic options…

November 17, 2020

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Interim pages omitted …
  • Page 14
  • Go to Next Page »

Primary Sidebar

Latest News

  • New Guidelines for Platelet Transfusion Recommend Restrictive Strategies

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley